JW Pharmaceutical Corporation
Símbolo: 001067.KS
KSC
59500
KRWPrecio de mercado actual
36.7808
Ratio PER
0.4062
Ratio PEG
698.35B
Capitalización MRK
- 0.01%
Rendimiento DIV
JW Pharmaceutical Corporation (001067-KS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 370559.84 | 92838 | 149678.7 | 65666.1 | |||||||||||||||||
balance-sheet.row.short-term-investments | 282046.71 | 76929.2 | 115780.8 | 32299.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 692398.22 | 173629.3 | 162146.2 | 192840 | |||||||||||||||||
balance-sheet.row.inventory | 456503.25 | 106091.4 | 111668.4 | 102527.6 | |||||||||||||||||
balance-sheet.row.other-current-assets | 11337.77 | 5532.7 | 1963.7 | 5417.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1530799.07 | 378091.4 | 425457.1 | 366451.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 624681 | 155723.7 | 123048.1 | 118392.3 | |||||||||||||||||
balance-sheet.row.goodwill | 11794.82 | 1404.5 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 92583.31 | 28952 | 16266.2 | 21473.1 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 104378.13 | 30356.4 | 16266.2 | 21473.1 | |||||||||||||||||
balance-sheet.row.long-term-investments | 20291.53 | 52498.2 | -81554 | 69814.7 | |||||||||||||||||
balance-sheet.row.tax-assets | 89655.86 | 20623.3 | 21811.3 | 20802.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 261266.16 | 7745.9 | 122944.1 | 36119.4 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 1100272.68 | 266947.4 | 202515.7 | 266601.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 2631071.75 | 645038.8 | 627972.8 | 633053.1 | |||||||||||||||||
balance-sheet.row.account-payables | 262951.71 | 73847.2 | 82907.9 | 51642.9 | |||||||||||||||||
balance-sheet.row.short-term-debt | 667547.61 | 117404.6 | 207693 | 123074.6 | |||||||||||||||||
balance-sheet.row.tax-payables | 57750.41 | 11113.5 | 13983.9 | 29008.6 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 197297.36 | 30000 | 1849.3 | 122070.1 | |||||||||||||||||
Deferred Revenue Non Current | 1431.95 | 1325.4 | 0 | -13199.8 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 5294.44 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 206288.74 | 89585.4 | 82814.9 | 35045.6 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 309778.22 | 92671.2 | 22082.6 | 161836 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 112201.29 | 22875.8 | 3102.6 | 2600.9 | |||||||||||||||||
balance-sheet.row.total-liab | 1624750.34 | 379598.3 | 402213.7 | 444513.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 15209.45 | 3173.6 | 3973 | 3352.6 | |||||||||||||||||
balance-sheet.row.common-stock | 229188.67 | 57925.9 | 55445.2 | 53849.8 | |||||||||||||||||
balance-sheet.row.retained-earnings | 391080.62 | 92612 | 89129.8 | 58594.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 82131.39 | 53896.2 | 51771.8 | 52070.7 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 303426.98 | 57832.7 | 40034.3 | 33327 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1021037.11 | 265440.5 | 240354.1 | 201194.8 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 2631071.75 | 645038.8 | 627972.8 | 633053.1 | |||||||||||||||||
balance-sheet.row.minority-interest | -14715.71 | 0 | -14595.1 | -12655.2 | |||||||||||||||||
balance-sheet.row.total-equity | 1006321.4 | 265440.5 | 225759 | 188539.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 2631071.75 | - | - | - | |||||||||||||||||
Total Investments | 302338.24 | 129427.3 | 34226.8 | 102114.3 | |||||||||||||||||
balance-sheet.row.total-debt | 887720.78 | 170280.4 | 209542.3 | 245144.7 | |||||||||||||||||
balance-sheet.row.net-debt | 799207.66 | 154371.6 | 175644.4 | 211778.2 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 37151.21 | 35096 | 29852.6 | -1441.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 22574.6 | 22444.6 | 16836.3 | 16111.7 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -20262.51 | -20262.5 | -6169.7 | -46055.8 | |||||||||||||||||
cash-flows.row.account-receivables | -3162.23 | -3162.2 | -4352.5 | -41296.6 | |||||||||||||||||
cash-flows.row.inventory | 8916.8 | 8916.8 | -11541.3 | -2655.1 | |||||||||||||||||
cash-flows.row.account-payables | -9535.56 | -9535.6 | 31652.3 | 3729.7 | |||||||||||||||||
cash-flows.row.other-working-capital | -16481.52 | -16481.5 | -21928.1 | -5833.7 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 47693.94 | 49879.1 | 16245.2 | 49509.5 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 87157.24 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -38561.91 | -42967.2 | -12352.5 | -12901.6 | |||||||||||||||||
cash-flows.row.acquisitions-net | -14325.59 | -12034 | -40.9 | 385 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -61344 | -61344 | -73817.4 | -140023.5 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 69604.03 | 69604 | 47473.7 | 141101.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | -19152.8 | -17093.1 | 19817.9 | -11430.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -63780.27 | -63834.3 | -18919.2 | -22869.2 | |||||||||||||||||
cash-flows.row.debt-repayment | -216351.12 | -28189.8 | -177004.4 | -98658.1 | |||||||||||||||||
cash-flows.row.common-stock-issued | 7880.94 | -3873 | 10000 | 398.5 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -260.87 | -260.9 | -281.6 | -412.3 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -8813.7 | -7352 | -7149.5 | |||||||||||||||||
cash-flows.row.other-financing-activites | 176299.39 | -54 | 137730.5 | 133023 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -41245.33 | -41191.3 | -36907.5 | 27201.6 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -120.69 | -120.7 | -406.4 | 458.7 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -17989.06 | -17989.1 | 531.4 | 22915.1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 88513.13 | 15908.9 | 33897.9 | 33366.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 106502.18 | 33897.9 | 33366.5 | 10451.3 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 87157.24 | 87157.2 | 56764.4 | 18124 | |||||||||||||||||
cash-flows.row.capital-expenditure | -38561.91 | -42967.2 | -12352.5 | -12901.6 | |||||||||||||||||
cash-flows.row.free-cash-flow | 48595.33 | 44190 | 44411.9 | 5222.4 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 748526.71 | 748526.7 | 684351.1 | 606584.9 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 412984.31 | 412854.3 | 396396.6 | 372208.6 | |||||||||||||||||
income-statement-row.row.gross-profit | 335542.4 | 335672.4 | 287954.5 | 234376.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 33671.36 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 204703.62 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 35443.42 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -253431.49 | -36136.8 | 64701.4 | 67954.7 | |||||||||||||||||
income-statement-row.row.operating-expenses | -2317.17 | 238911.4 | 225175.5 | 203176.5 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 474255.45 | 651765.7 | 621572 | 575385.1 | |||||||||||||||||
income-statement-row.row.interest-income | 5893.15 | 5893.1 | 5321.5 | 1654.8 | |||||||||||||||||
income-statement-row.row.interest-expense | 9617.04 | 12561.7 | 9386.8 | 7336.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 35443.42 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -45650.78 | -42545.6 | -17598.9 | -10667.2 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -253431.49 | -36136.8 | 64701.4 | 67954.7 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -45650.78 | -42545.6 | -17598.9 | -10667.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 9617.04 | 12561.7 | 9386.8 | 7336.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 179363.79 | 22444.6 | 19571.5 | 16180.7 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 279325.21 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 99961.42 | 96761 | 62960.9 | 31199.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 54310.64 | 54215.4 | 45362 | 20532.7 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 16406.19 | 16406.2 | 15509.4 | 21974.1 | |||||||||||||||||
income-statement-row.row.net-income | 37006.33 | 37006.3 | 31891.7 | -1441.5 |
Preguntas frecuentes
Cuánto es JW Pharmaceutical Corporation (001067.KS) activos totales?
JW Pharmaceutical Corporation (001067.KS) los activos totales son 645038796101.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 389220837356.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.448.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 2124.292.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.049.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.134.
¿Qué es JW Pharmaceutical Corporation (001067.KS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 37006333990.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 170280439662.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 238911370958.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 15908868301.000.